2026 ICD-10-CM Diagnosis Code D57.04Hb-SS disease with dactylitis
ICD-10-CM Codes›D50–D89›D55-D59›D57
- Billable — Valid for Submission
- Chronic Condition
D57.04 is a billable ICD-10-CM diagnosis code for Hb-SS disease with dactylitis. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 811 through 812. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Sickle cell trait/anemia.
Code Identity
Code Classification
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- sickle-cell - D57.04
- Hb SS - D57.04
- Disease, diseased - See Also: Syndrome;
- with
- with
- dactylitis - D57.04
- sickle-cell - D57.1
- with
- with
- dactylitis - D57.04
- dactylitis - D57.04
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Dactylitis
- sickle-cell
- Dactylitis
- sickle-cell
- Hb SS
- Disease, diseased
- hemoglobin or Hb
- S or SS
- with
- crisis (painful)
- with
- dactylitis
- Disease, diseased
- sickle-cell
- with
- crisis (painful)
- with
- dactylitis
- Disease, diseased
- sickle-cell
- with
- dactylitis
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Code History & ChangesHistory
Replacement D57.04 replaces the following previously assigned code(s):
- D57.09 - Hb-SS disease with crisis with other specified complication
Questions About D57.04Overview
Is D57.04 (Hb-SS disease with crisis) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report Hb-SS disease with dactylitis on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does D57.04 group to?
When Hb-SS disease with dactylitis is the principal diagnosis on an inpatient stay, it groups to MS-DRG 811, 812, with relative weights from 0.9182 to 1.4043 depending on complications. Higher weights mean higher Medicare reimbursement.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
